Zenas BioPharma

ZBIONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.154 B

$33.05 +1.54%

Close of 22 Sept 2026

Revenue

$10.0M

#3153 by revenue

Earnings

-$377.7M

Loss-making

Shares outstanding

65,176,723

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#102Bausch Health CompaniesBHC$2.17B
#103Trevi TherapeuticsTRVI$2.17B
#104Zenas BioPharmaZBIO$2.15B
#105Nuvation BioNUVB$2.14B
#106Braveheart BioBRVE$2.13B

What if Zenas BioPharma were worth as much as…

Open the what-if tool →

Gold $30.2T

$463,876.80

Per share 14,036× higher

Bitcoin $1.74T

$26,722.04

Per share 809× higher

Nvidia $5.52T

$84,627.87

Per share 2,561× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Zenas BioPharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.